Close
CDMO Safety Testing 2026
Novotech

Accenture and Google Cloud Collaborate to Help Life Sciences Companies Advance the Discovery, Development and Delivery of Innovative Therapies

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

Bioprocess Analytics Improving Biologics Manufacturing

The immense complexity of modern biopharmaceutical production is being navigated through the strategic and systematic application of bioprocess analytics improving biologics manufacturing. By leveraging real-time data streams and advanced monitoring tools, manufacturers can gain a granular, molecular-level understanding of cellular behavior and the surrounding environmental conditions within the bioreactor. This proactive, data-driven approach allows for immediate, automated adjustments that optimize therapeutic yield, ensure absolute product consistency, and significantly streamline the arduous path toward commercial-scale production in a highly regulated global environment.

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic...
- Advertisement -

Accenture and Google Cloud announced that Google Cloud will be the cloud technology provider for Accenture’s INTIENT life sciences industry platform.

The new, multi-year agreement brings Google’s cloud and artificial intelligence capabilities together with Accenture’s life sciences services and platforms and is intended to help life sciences organizations make their data more accessible, secure and valuable.

The INTIENT platform provides life sciences organizations with end-to-end capabilities from discovery and research to clinical development and the delivery of treatments. Accenture launched INTIENT in May 2019, building on more than seven years of collaboration with over 25 life sciences companies to develop and deploy platform technology solutions.

“INTIENT will advance Accenture’s and Google Cloud’s shared mission to empower life sciences organizations with intelligent solutions that help bring innovative treatments to patients around the world, with greater speed, safety, and efficacy,” said Simon Eaves, group chief executive of Products at Accenture. “Together, we can deliver exceptional value to clients at a rapid pace.”

Google Cloud’s architecture supports open source technology that will enable Accenture to expand the capabilities of INTIENT by allowing partners, independent software vendors, and content providers to rapidly develop and provide additional solutions that extend the value of the platform.

Tariq Shaukat, president at Google Cloud, said, “We’re excited to partner with Accenture to transform the life sciences industry with cloud technologies. Our shared goal is to accelerate developments in treatments by leveraging powerful Google Cloud capabilities, such as AI and data analytics, to gain insights that correlate symptoms, events, and treatments in new and unexpected ways.”

Under the terms of the agreement, Google Cloud will be the cloud technology provider for current and future solutions that are a part of the Accenture INTIENT platform for life sciences. The agreement is an extension of the partnership between Accenture and Google built over the last eight years. A key milestone in the relationship was the July 2018 launch of the Accenture Google Cloud Business Group, which helps companies use Google Cloud technology to deliver superior customer experiences and accelerate their digital transformation journeys.

About Accenture

Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions — underpinned by the world’s largest delivery network — Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With 505,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives. Visit us at www.accenture.com.

About Google Cloud

Google Cloud provides organizations with leading infrastructure, platform capabilities and industry solutions, along with expertise, to reinvent their business with data-powered innovation on modern computing infrastructure. We deliver enterprise-grade cloud solutions that leverage Google’s cutting-edge technology to help companies operate more efficiently, modernize for growth and innovate for the future. Customers in more than 150 countries turn to Google Cloud as their trusted partner to solve their most critical business problems.

 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

Bioprocess Analytics Improving Biologics Manufacturing

The immense complexity of modern biopharmaceutical production is being navigated through the strategic and systematic application of bioprocess analytics improving biologics manufacturing. By leveraging real-time data streams and advanced monitoring tools, manufacturers can gain a granular, molecular-level understanding of cellular behavior and the surrounding environmental conditions within the bioreactor. This proactive, data-driven approach allows for immediate, automated adjustments that optimize therapeutic yield, ensure absolute product consistency, and significantly streamline the arduous path toward commercial-scale production in a highly regulated global environment.

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic...

How to Source the Best Color Spectrophotometers and Colorimeters for Pharma QC

Color consistency is critical in pharmaceutical quality control (QC)....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »